CDKAL_HUMAN - dbPTM
CDKAL_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CDKAL_HUMAN
UniProt AC Q5VV42
Protein Name Threonylcarbamoyladenosine tRNA methylthiotransferase
Gene Name CDKAL1
Organism Homo sapiens (Human).
Sequence Length 579
Subcellular Localization Endoplasmic reticulum membrane
Single-pass membrane protein . Is a tail-anchored protein that exploits the TCR40 pathway for insertion into the endoplasmic reticulum.
Protein Description Catalyzes the methylthiolation of N6-threonylcarbamoyladenosine (t(6)A), leading to the formation of 2-methylthio-N6-threonylcarbamoyladenosine (ms(2)t(6)A) at position 37 in tRNAs that read codons beginning with adenine..
Protein Sequence MPSASCDTLLDDIEDIVSQEDSKPQDRHFVRKDVVPKVRRRNTQKYLQEEENSPPSDSTIPGIQKIWIRTWGCSHNNSDGEYMAGQLAAYGYKITENASDADLWLLNSCTVKNPAEDHFRNSIKKAQEENKKIVLAGCVPQAQPRQDYLKGLSIIGVQQIDRVVEVVEETIKGHSVRLLGQKKDNGRRLGGARLDLPKIRKNPLIEIISINTGCLNACTYCKTKHARGNLASYPIDELVDRAKQSFQEGVCEIWLTSEDTGAYGRDIGTNLPTLLWKLVEVIPEGAMLRLGMTNPPYILEHLEEMAKILNHPRVYAFLHIPVQSASDSVLMEMKREYCVADFKRVVDFLKEKVPGITIATDIICGFPGETDQDFQETVKLVEEYKFPSLFINQFYPRPGTPAAKMEQVPAQVKKQRTKDLSRVFHSYSPYDHKIGERQQVLVTEESFDSKFYVAHNQFYEQVLVPKNPAFMGKMVEVDIYESGKHFMKGQPVSDAKVYTPSISKPLAKGEVSGLTKDFRNGLGNQLSSGSHTSAASQCDSASSRMVLPMPRLHQDCALRMSVGLALLGLLFAFFVKVYN
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
3Phosphorylation-----MPSASCDTLL
-----CCCCCHHHHH
31.3623663014
5Phosphorylation---MPSASCDTLLDD
---CCCCCHHHHHHH
19.5023663014
6Glutathionylation--MPSASCDTLLDDI
--CCCCCHHHHHHHH
4.6622555962
8PhosphorylationMPSASCDTLLDDIED
CCCCCHHHHHHHHHH
33.2823663014
18PhosphorylationDDIEDIVSQEDSKPQ
HHHHHHHHCCCCCCC
28.3423401153
22PhosphorylationDIVSQEDSKPQDRHF
HHHHCCCCCCCCCCC
45.5423401153
37UbiquitinationVRKDVVPKVRRRNTQ
CCCCHHHHHHHHHHH
36.4429967540
43PhosphorylationPKVRRRNTQKYLQEE
HHHHHHHHHHHHHHH
25.3222817900
45UbiquitinationVRRRNTQKYLQEEEN
HHHHHHHHHHHHHHC
45.9821906983
45 (in isoform 3)Ubiquitination-45.9821906983
45 (in isoform 1)Ubiquitination-45.9821890473
46PhosphorylationRRRNTQKYLQEEENS
HHHHHHHHHHHHHCC
12.1029978859
53PhosphorylationYLQEEENSPPSDSTI
HHHHHHCCCCCCCCC
41.2825159151
56PhosphorylationEEENSPPSDSTIPGI
HHHCCCCCCCCCCCC
47.8022199227
58PhosphorylationENSPPSDSTIPGIQK
HCCCCCCCCCCCCEE
32.3529978859
59PhosphorylationNSPPSDSTIPGIQKI
CCCCCCCCCCCCEEE
35.8629978859
65UbiquitinationSTIPGIQKIWIRTWG
CCCCCCEEEEEEEEC
37.7823503661
65 (in isoform 3)Ubiquitination-37.78-
70 (in isoform 3)Phosphorylation-19.6422210691
80 (in isoform 2)Ubiquitination-27.9621890473
95PhosphorylationAAYGYKITENASDAD
HHHCCEECCCCCCCC
21.0226074081
95 (in isoform 3)Phosphorylation-21.0222210691
99PhosphorylationYKITENASDADLWLL
CEECCCCCCCCEEEE
44.9328464451
112UbiquitinationLLNSCTVKNPAEDHF
EEECCCCCCHHHHHH
38.7729967540
122PhosphorylationAEDHFRNSIKKAQEE
HHHHHHHHHHHHHHH
31.3723401153
124UbiquitinationDHFRNSIKKAQEENK
HHHHHHHHHHHHHHC
41.7129967540
127UbiquitinationRNSIKKAQEENKKIV
HHHHHHHHHHHCCEE
68.3724816145
131UbiquitinationKKAQEENKKIVLAGC
HHHHHHHCCEEEEEC
47.35-
132UbiquitinationKAQEENKKIVLAGCV
HHHHHHCCEEEEECC
50.0229967540
148PhosphorylationQAQPRQDYLKGLSII
CCCCCCHHHHCCEEE
11.2822817900
150 (in isoform 1)Ubiquitination-52.1321890473
150UbiquitinationQPRQDYLKGLSIIGV
CCCCHHHHCCEEEEE
52.1321906983
170PhosphorylationVVEVVEETIKGHSVR
HHHHHHHHHCCCCEE
17.9324719451
172UbiquitinationEVVEETIKGHSVRLL
HHHHHHHCCCCEEEC
58.9729967540
175PhosphorylationEETIKGHSVRLLGQK
HHHHCCCCEEECEEE
20.0126434776
183UbiquitinationVRLLGQKKDNGRRLG
EEECEEECCCCCCCC
48.8424816145
198UbiquitinationGARLDLPKIRKNPLI
CEECCCCHHCCCCCE
63.54-
202UbiquitinationDLPKIRKNPLIEIIS
CCCHHCCCCCEEEEE
27.1127667366
220PhosphorylationGCLNACTYCKTKHAR
CCHHHHHHHCCCCCC
7.5728387310
230UbiquitinationTKHARGNLASYPIDE
CCCCCCCCCCCCHHH
3.5921890473
243UbiquitinationDELVDRAKQSFQEGV
HHHHHHHHHHHHHCC
47.58-
287SulfoxidationEVIPEGAMLRLGMTN
HHCCCCCCHHCCCCC
3.0921406390
307UbiquitinationEHLEEMAKILNHPRV
HHHHHHHHHHCCCEE
46.55-
315PhosphorylationILNHPRVYAFLHIPV
HHCCCEEEEEEECCC
7.91-
343UbiquitinationEYCVADFKRVVDFLK
HHHHHHHHHHHHHHH
44.8429967540
350UbiquitinationKRVVDFLKEKVPGIT
HHHHHHHHHHCCCEE
56.3229967540
352UbiquitinationVVDFLKEKVPGITIA
HHHHHHHHCCCEEEE
52.7429967540
400PhosphorylationQFYPRPGTPAAKMEQ
CCCCCCCCCCHHHHH
16.6728555341
404UbiquitinationRPGTPAAKMEQVPAQ
CCCCCCHHHHHCCHH
45.1129967540
405SulfoxidationPGTPAAKMEQVPAQV
CCCCCHHHHHCCHHH
3.6021406390
413UbiquitinationEQVPAQVKKQRTKDL
HHCCHHHHHHHHHHH
30.9824816145
414UbiquitinationQVPAQVKKQRTKDLS
HCCHHHHHHHHHHHH
46.27-
425 (in isoform 2)Ubiquitination-23.9921890473
433UbiquitinationSYSPYDHKIGERQQV
HCCCCCCCCCCCEEE
49.8929967540
446PhosphorylationQVLVTEESFDSKFYV
EEEEEECCCCCCEEE
28.2825690035
449PhosphorylationVTEESFDSKFYVAHN
EEECCCCCCEEEECC
23.7425690035
452PhosphorylationESFDSKFYVAHNQFY
CCCCCCEEEECCCHH
10.6427642862
459PhosphorylationYVAHNQFYEQVLVPK
EEECCCHHEEECCCC
8.8328796482
466UbiquitinationYEQVLVPKNPAFMGK
HEEECCCCCCCCCCC
68.99-
467UbiquitinationEQVLVPKNPAFMGKM
EEECCCCCCCCCCCE
27.3627667366
484UbiquitinationVDIYESGKHFMKGQP
EEEECCCCCCCCCCC
42.84-
488UbiquitinationESGKHFMKGQPVSDA
CCCCCCCCCCCCCCC
54.1527667366
495UbiquitinationKGQPVSDAKVYTPSI
CCCCCCCCEEECCCC
8.8421890473
496UbiquitinationGQPVSDAKVYTPSIS
CCCCCCCEEECCCCC
40.5433845483
498PhosphorylationPVSDAKVYTPSISKP
CCCCCEEECCCCCCC
16.5429978859
499PhosphorylationVSDAKVYTPSISKPL
CCCCEEECCCCCCCC
17.3421712546
501PhosphorylationDAKVYTPSISKPLAK
CCEEECCCCCCCCCC
31.5223186163
503PhosphorylationKVYTPSISKPLAKGE
EEECCCCCCCCCCCC
32.3424719451
504UbiquitinationVYTPSISKPLAKGEV
EECCCCCCCCCCCCC
42.2433845483
508UbiquitinationSISKPLAKGEVSGLT
CCCCCCCCCCCCCCC
64.3933845483
516UbiquitinationGEVSGLTKDFRNGLG
CCCCCCCHHHHCCCC
60.9723000965
516 (in isoform 1)Ubiquitination-60.9721890473
527PhosphorylationNGLGNQLSSGSHTSA
CCCCCCCCCCCCCCH
23.9228450419
528PhosphorylationGLGNQLSSGSHTSAA
CCCCCCCCCCCCCHH
53.5628450419
530PhosphorylationGNQLSSGSHTSAASQ
CCCCCCCCCCCHHHH
26.0728450419
532PhosphorylationQLSSGSHTSAASQCD
CCCCCCCCCHHHHCC
23.0429978859
533PhosphorylationLSSGSHTSAASQCDS
CCCCCCCCHHHHCCC
19.2023186163
536PhosphorylationGSHTSAASQCDSASS
CCCCCHHHHCCCCCC
30.9328450419
543PhosphorylationSQCDSASSRMVLPMP
HHCCCCCCCCEECCC
24.9030576142

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of CDKAL_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CDKAL_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CDKAL_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
TTYH3_HUMANTTYH3physical
28514442
BPIB1_HUMANBPIFB1physical
28514442
DYN1_HUMANDNM1physical
28514442
CIAO1_HUMANCIAO1physical
28514442
TYW3_HUMANTYW3physical
28514442
DYN3_HUMANDNM3physical
28514442
TYW1B_HUMANTYW1Bphysical
28514442

Drug and Disease Associations
Kegg Disease
H00409 Type II diabetes mellitus
OMIM Disease
125853Diabetes mellitus, non-insulin-dependent (NIDDM)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CDKAL_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-499, AND MASSSPECTROMETRY.

TOP